Special Issue "Recent Advances in ELISPOT Research"
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: closed (30 June 2017) | Viewed by 19234
Interests: investigating the mechanisms underlying constitutive and induced heteromerization of opioid receptors
Special Issues, Collections and Topics in MDPI journals
Special Issue in Cells: Oligomerization & Trafficking of Opioid Receptors
Special Issue in Cells: Feature Papers 2013
Special Issue in Cells: 2018 Select Papers by Cells’ Editorial Board Members
Topical Collection in Cells: Celebrating the First Impact Factor of Cells
Special Issue in Cells: 10th Anniversary of Cells—Advances in Cell Techniques
Special Issue in Cells: Advances in Cell Techniques
Topical Collection in Cells: Exclusive Papers from Editorial Board Members and Invited Scholars in Cells
It appears that ELISPOT is a very conservative technique limited, unlike ELISA, to analyzing a handful of proteins. There is some truth to it, because this limitation is due to inherent nature of ELISPOT assay: Only proteins secreted from live cells are to be detected. However, ELISA can be used for both, secreted proteins from live cells, as well as non-secreted intracellular proteins in cell lysates. In spite of detecting a limited number of secreted proteins, ELISPOT offers unsurpassed detection sensitivity that is a hundred times (or even more) sensitive compared to ELISA. In addition to its exceptional sensitivity, ELISPOT allows precise quantification of bona fide secreting cells, which is not possible using any other technique that is currently available to researchers. Initially developed as a research tool, ELISPOT has recently entered a diagnostic market where it firmly holds a unique niche.
This Special Issue “Recent Advances in ELISPOT Research” is the third issue in our ELISPOT series, which has received a very positive feedback from the global research community. Our current Special Issue is welcoming research papers and review articles, as well as entirely technique-related articles. We invite papers on ELISPOT applications for human and animal diagnostics and novel “non-conventional” areas of its application, including environment protection, analysis of non-mammalian cells, and super-sensitive multiplexing.
Dr. Alexander E. Kalyuzhny
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cancer research
- vaccine development